CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,402,887
+$3,742,201 QoQ
Shares Held
1,429,842
+5.4% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. CPRX ranks #40 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,402,887 | 1,429,842 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,660,686 | 1,356,499 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,240,203 | 1,331,990 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $31,163,630 | 1,436,112 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $32,174,196 | 1,326,771 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $26,023,324 | 1,246,925 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $23,214,730 | 1,167,743 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,301,385 | 1,116,939 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $17,144,410 | 1,075,559 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,075,957 | 956,333 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,770,312 | 921,327 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,602,872 | 863,309 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $20,213,921 | 1,219,175 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,201,900 | 1,247,414 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,600,138 | 1,215,911 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,281,663 | 1,181,407 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,892,015 | 831,365 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,550,018 | 819,796 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,246,593 | 801,244 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,595,624 | 799,239 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,470,349 | 969,707 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,322,431 | 994,740 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,673,885 | 900,298 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,183,839 | 905,593 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,329,707 | 864,859 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||